Do analysts rate LNSR or TMDIF?

LENSAR currently has a consensus price target of $10.00, indicating a potential upside of 56.25%. Given LENSAR's stronger consensus rating and higher possible upside, analysts clearly believe LENSAR is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LENSAR 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is LNSR or TMDIF more profitable?

LENSAR has a net margin of 50.94% compared to Titan Medical's net margin of 0.00%. Titan Medical's return on equity of -82.31% beat LENSAR's return on equity. Company Net Margins Return on Equity Return on Assets LENSAR 50.94% -183.19% 42.26% Titan Medical N/A -82.31% -51.47%

Do analysts prefer TMDIF or ECOR?

electroCore has a consensus target price of $18.00, indicating a potential upside of 105.25%. Given electroCore's stronger consensus rating and higher possible upside, analysts clearly believe electroCore is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 electroCore 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is TMDIF or ECOR more profitable?

Titan Medical has a net margin of 0.00% compared to electroCore's net margin of -44.08%. Titan Medical's return on equity of -82.31% beat electroCore's return on equity. Company Net Margins Return on Equity Return on Assets Titan Medical N/A -82.31% -51.47% electroCore -44.08% -1,956.38% -83.30%

Do analysts prefer NYXH or TMDIF?

Nyxoah presently has a consensus target price of $7.00, indicating a potential upside of 306.98%. Given Nyxoah's stronger consensus rating and higher probable upside, research analysts plainly believe Nyxoah is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation and earnings, NYXH or TMDIF?

Titan Medical has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nyxoah $11.33M 5.88 -$101.92M -$2.48 N/A Titan Medical $17.63M 1.16 $6.95M $0.05 3.60

Is NYXH or TMDIF more profitable?

Titan Medical has a net margin of 0.00% compared to Nyxoah's net margin of -543.21%. Titan Medical's return on equity of -82.31% beat Nyxoah's return on equity. Company Net Margins Return on Equity Return on Assets Nyxoah -543.21% -163.73% -80.24% Titan Medical N/A -82.31% -51.47%

Do analysts recommend TMDIF or DXR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Daxor 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has stronger earnings & valuation, TMDIF or DXR?

Titan Medical has higher revenue and earnings than Daxor. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Titan Medical $17.63M 1.16 $6.95M $0.05 3.60 Daxor N/A N/A N/A N/A N/A

Is TMDIF or DXR more profitable?

Daxor's return on equity of 0.00% beat Titan Medical's return on equity. Company Net Margins Return on Equity Return on Assets Titan Medical N/A -82.31% -51.47% Daxor N/A N/A N/A

Do analysts recommend TMDIF or POCI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Titan Medical (TMDIF) Competitors

$0.18 0.00 (0.00%)

As of 07/2/2026

Compare

TMDIF vs. LNSR, ECOR, NYXH, DXR, and POCI

Should you buy Titan Medical stock or one of its competitors? MarketBeat compares Titan Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Titan Medical include LENSAR (LNSR), electroCore (ECOR), Nyxoah (NYXH), Daxor (DXR), and Precision Optics (POCI). These companies are all part of the "medical equipment" industry.

How does Titan Medical compare to LENSAR?

LENSAR (NASDAQ:LNSR) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

In the previous week, LENSAR's average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.

Company	Overall Sentiment
LENSAR	Neutral
Titan Medical	Neutral

Titan Medical has lower revenue, but higher earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LENSAR	$58.44M	1.34	-$34.28M	-$0.58	N/A
Titan Medical	$17.63M	1.16	$6.95M	$0.05	3.60

LENSAR has a net margin of 50.94% compared to Titan Medical's net margin of 0.00%. Titan Medical's return on equity of -82.31% beat LENSAR's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LENSAR	50.94%	-183.19%	42.26%
Titan Medical	N/A	-82.31%	-51.47%

LENSAR currently has a consensus price target of $10.00, indicating a potential upside of 56.25%. Given LENSAR's stronger consensus rating and higher possible upside, analysts clearly believe LENSAR is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LENSAR	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

LENSAR has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market.

40.2% of LENSAR shares are held by institutional investors. Comparatively, 0.0% of Titan Medical shares are held by institutional investors. 65.8% of LENSAR shares are held by insiders. Comparatively, 0.0% of Titan Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

LENSAR beats Titan Medical on 9 of the 14 factors compared between the two stocks.

How does Titan Medical compare to electroCore?

Titan Medical (NASDAQ:TMDIF) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Titan Medical has higher earnings, but lower revenue than electroCore. electroCore is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	1.16	$6.95M	$0.05	3.60
electroCore	$34.90M	2.08	-$13.97M	-$1.77	N/A

Titan Medical has a net margin of 0.00% compared to electroCore's net margin of -44.08%. Titan Medical's return on equity of -82.31% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
electroCore	-44.08%	-1,956.38%	-83.30%

In the previous week, Titan Medical's average media sentiment score of 0.00 equaled electroCore'saverage media sentiment score.

Company	Overall Sentiment
Titan Medical	Neutral
electroCore	Neutral

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by company insiders. Comparatively, 13.8% of electroCore shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Titan Medical has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market. Comparatively, electroCore has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

electroCore has a consensus target price of $18.00, indicating a potential upside of 105.25%. Given electroCore's stronger consensus rating and higher possible upside, analysts clearly believe electroCore is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Titan Medical and electroCore tied by winning 7 of the 14 factors compared between the two stocks.

How does Titan Medical compare to Nyxoah?

Nyxoah (NASDAQ:NYXH) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

Nyxoah has a beta of 1.61, meaning that its share price is 61% more volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market.

Titan Medical has a net margin of 0.00% compared to Nyxoah's net margin of -543.21%. Titan Medical's return on equity of -82.31% beat Nyxoah's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nyxoah	-543.21%	-163.73%	-80.24%
Titan Medical	N/A	-82.31%	-51.47%

In the previous week, Nyxoah had 3 more articles in the media than Titan Medical. MarketBeat recorded 3 mentions for Nyxoah and 0 mentions for Titan Medical. Nyxoah's average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.

Company	Overall Sentiment
Nyxoah	Neutral
Titan Medical	Neutral

Titan Medical has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$11.33M	5.88	-$101.92M	-$2.48	N/A
Titan Medical	$17.63M	1.16	$6.95M	$0.05	3.60

0.0% of Titan Medical shares are owned by institutional investors. 17.1% of Nyxoah shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Nyxoah presently has a consensus target price of $7.00, indicating a potential upside of 306.98%. Given Nyxoah's stronger consensus rating and higher probable upside, research analysts plainly believe Nyxoah is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Titan Medical beats Nyxoah on 8 of the 15 factors compared between the two stocks.

How does Titan Medical compare to Daxor?

Titan Medical (NASDAQ:TMDIF) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.

Daxor's return on equity of 0.00% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Daxor	N/A	N/A	N/A

Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Daxor has a beta of 0.26, suggesting that its stock price is 74% less volatile than the broader market.

In the previous week, Titan Medical's average media sentiment score of 0.00 equaled Daxor'saverage media sentiment score.

Company	Overall Sentiment
Titan Medical	Neutral
Daxor	Neutral

0.0% of Titan Medical shares are held by institutional investors. Comparatively, 1.3% of Daxor shares are held by institutional investors. 0.0% of Titan Medical shares are held by insiders. Comparatively, 51.5% of Daxor shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Titan Medical has higher revenue and earnings than Daxor.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	1.16	$6.95M	$0.05	3.60
Daxor	N/A	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Daxor	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Daxor beats Titan Medical on 6 of the 8 factors compared between the two stocks.

How does Titan Medical compare to Precision Optics?

Titan Medical (NASDAQ:TMDIF) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market. Comparatively, Precision Optics has a beta of 0.32, indicating that its stock price is 68% less volatile than the broader market.

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by company insiders. Comparatively, 14.4% of Precision Optics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Titan Medical has higher earnings, but lower revenue than Precision Optics. Precision Optics is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	1.16	$6.95M	$0.05	3.60
Precision Optics	$19.09M	2.90	-$5.78M	-$0.63	N/A

Titan Medical has a net margin of 0.00% compared to Precision Optics' net margin of -17.03%. Precision Optics' return on equity of -37.47% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Precision Optics	-17.03%	-37.47%	-19.96%

In the previous week, Precision Optics had 2 more articles in the media than Titan Medical. MarketBeat recorded 2 mentions for Precision Optics and 0 mentions for Titan Medical. Titan Medical's average media sentiment score of 0.00 equaled Precision Optics'average media sentiment score.

Company	Overall Sentiment
Titan Medical	Neutral
Precision Optics	Neutral

Summary

Precision Optics beats Titan Medical on 8 of the 13 factors compared between the two stocks.

Get Titan Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMDIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMDIF vs. The Competition

Export

Metric	Titan Medical	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$20.52M	$46.05M	$7.16B	$12.48B
Dividend Yield	N/A	1.08%	2.66%	6.52%
P/E Ratio	-0.14	20.75	28.02	24.70
Price / Sales	1.16	31.08	540.37	99.49
Price / Cash	0.02	18.86	49.26	57.09
Price / Book	0.17	8.46	10.96	6.46
Net Income	$6.95M	-$20.01M	$3.57B	$337.01M
7 Day Performance	6.89%	4.17%	2.12%	1.69%
1 Month Performance	-4.81%	5.11%	5.25%	3.81%
1 Year Performance	-35.75%	-3.58%	33.29%	23.90%

Titan Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMDIF Titan Medical	N/A	$0.18 flat	N/A	-35.8%	$20.52M	$17.63M	N/A	50
LNSR LENSAR	1.3532 of 5 stars	$5.69 +1.0%	$10.00 +75.9%	-51.5%	$69.82M	$58.44M	N/A	110	Gap Down
ECOR electroCore	3.0558 of 5 stars	$8.21 +4.7%	$18.00 +119.2%	+45.4%	$68.12M	$34.90M	N/A	50
NYXH Nyxoah	2.3641 of 5 stars	$1.65 -1.2%	$7.00 +324.2%	-77.9%	$63.95M	$11.33M	N/A	110
DXR Daxor	N/A	$10.27 +2.5%	N/A	+7.0%	$59.98M	N/A	N/A	37	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TMDIF) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Titan Medical (TMDIF) Competitors

TMDIF vs. LNSR, ECOR, NYXH, DXR, and POCI

How does Titan Medical compare to LENSAR?

Summary

How does Titan Medical compare to electroCore?

Summary

How does Titan Medical compare to Nyxoah?

Summary

How does Titan Medical compare to Daxor?

Summary

How does Titan Medical compare to Precision Optics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDIF vs. The Competition

Titan Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Titan Medical (TMDIF) Competitors

TMDIF vs. LNSR, ECOR, NYXH, DXR, and POCI

How does Titan Medical compare to LENSAR?

Does the media favor LNSR or TMDIF?

Which has stronger earnings & valuation, LNSR or TMDIF?

Is LNSR or TMDIF more profitable?

Do analysts rate LNSR or TMDIF?

Which has more risk and volatility, LNSR or TMDIF?

Do institutionals and insiders believe in LNSR or TMDIF?

Summary

How does Titan Medical compare to electroCore?

Which has stronger valuation and earnings, TMDIF or ECOR?

Is TMDIF or ECOR more profitable?

Does the media prefer TMDIF or ECOR?

Do institutionals & insiders believe in TMDIF or ECOR?

Which has more risk and volatility, TMDIF or ECOR?

Do analysts prefer TMDIF or ECOR?

Summary

How does Titan Medical compare to Nyxoah?

Which has more volatility and risk, NYXH or TMDIF?

Is NYXH or TMDIF more profitable?

Does the media favor NYXH or TMDIF?

Which has better valuation and earnings, NYXH or TMDIF?

Do institutionals and insiders believe in NYXH or TMDIF?

Do analysts prefer NYXH or TMDIF?

Summary

How does Titan Medical compare to Daxor?

Is TMDIF or DXR more profitable?

Which has more risk & volatility, TMDIF or DXR?

Does the media refer more to TMDIF or DXR?

Do insiders & institutionals believe in TMDIF or DXR?

Which has stronger earnings & valuation, TMDIF or DXR?

Do analysts recommend TMDIF or DXR?

Summary

How does Titan Medical compare to Precision Optics?

Do analysts recommend TMDIF or POCI?

Which has more volatility & risk, TMDIF or POCI?

Do institutionals and insiders hold more shares of TMDIF or POCI?

Which has better earnings and valuation, TMDIF or POCI?

Is TMDIF or POCI more profitable?

Does the media prefer TMDIF or POCI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDIF vs. The Competition

Titan Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools